These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

331 related articles for article (PubMed ID: 29535708)

  • 21. A role for leukocyte-derived IL-1RA in DC homeostasis revealed by increased susceptibility of IL-1RA-deficient mice to cutaneous leishmaniasis.
    Kautz-Neu K; Kostka SL; Dinges S; Iwakura Y; Udey MC; von Stebut E
    J Invest Dermatol; 2011 Aug; 131(8):1650-9. PubMed ID: 21525884
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Characterization of cross-protection by genetically modified live-attenuated Leishmania donovani parasites against Leishmania mexicana.
    Dey R; Natarajan G; Bhattacharya P; Cummings H; Dagur PK; Terrazas C; Selvapandiyan A; McCoy JP; Duncan R; Satoskar AR; Nakhasi HL
    J Immunol; 2014 Oct; 193(7):3513-27. PubMed ID: 25156362
    [TBL] [Abstract][Full Text] [Related]  

  • 23. NH36 and F3 Antigen-Primed Dendritic Cells Show Preserved Migrating Capabilities and CCR7 Expression and F3 Is Effective in Immunotherapy of Visceral Leishmaniasis.
    Nico D; Martins Almeida F; Maria Motta J; Soares Dos Santos Cardoso F; Freire-de-Lima CG; Freire-de-Lima L; de Luca PM; Maria Blanco Martinez A; Morrot A; Palatnik-de-Sousa CB
    Front Immunol; 2018; 9():967. PubMed ID: 29867949
    [TBL] [Abstract][Full Text] [Related]  

  • 24. TNF controls the infiltration of dendritic cells into the site of Leishmania major infection.
    Ritter U; Lechner A; Scharl K; Kiafard Z; Zwirner J; Körner H
    Med Microbiol Immunol; 2008 Mar; 197(1):29-37. PubMed ID: 17661079
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Deletion of IL-4Ralpha on CD4 T cells renders BALB/c mice resistant to Leishmania major infection.
    Radwanska M; Cutler AJ; Hoving JC; Magez S; Holscher C; Bohms A; Arendse B; Kirsch R; Hunig T; Alexander J; Kaye P; Brombacher F
    PLoS Pathog; 2007 May; 3(5):e68. PubMed ID: 17500591
    [TBL] [Abstract][Full Text] [Related]  

  • 26. The early IL-4 response to Leishmania major and the resulting Th2 cell maturation steering progressive disease in BALB/c mice are subject to the control of regulatory CD4+CD25+ T cells.
    Aseffa A; Gumy A; Launois P; MacDonald HR; Louis JA; Tacchini-Cottier F
    J Immunol; 2002 Sep; 169(6):3232-41. PubMed ID: 12218142
    [TBL] [Abstract][Full Text] [Related]  

  • 27. CD8 alpha- and Langerin-negative dendritic cells, but not Langerhans cells, act as principal antigen-presenting cells in leishmaniasis.
    Ritter U; Meissner A; Scheidig C; Körner H
    Eur J Immunol; 2004 Jun; 34(6):1542-50. PubMed ID: 15162423
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Early CD44(hi)CD4+ and CD44(hi)CD8+ T cell numbers and the absence of mannose-rich glycoconjugates determine the protective outcome of anti-leishmanial immunity.
    Kedzierski L; Curtis JM; Kedzierska K
    Parasitology; 2009 Jul; 136(8):833-40. PubMed ID: 19490731
    [TBL] [Abstract][Full Text] [Related]  

  • 29. MicroRNA155 Plays a Critical Role in the Pathogenesis of Cutaneous Leishmania major Infection by Promoting a Th2 Response and Attenuating Dendritic Cell Activity.
    Varikuti S; Verma C; Natarajan G; Oghumu S; Satoskar AR
    Am J Pathol; 2021 May; 191(5):809-816. PubMed ID: 33539779
    [TBL] [Abstract][Full Text] [Related]  

  • 30. IL-1 signalling is dispensable for protective immunity in Leishmania-resistant mice.
    Kautz-Neu K; Kostka SL; Dinges S; Iwakura Y; Udey MC; von Stebut E
    Exp Dermatol; 2011 Jan; 20(1):76-8. PubMed ID: 20955202
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Type I Interferon Signaling Is Required for CpG-Oligodesoxynucleotide-Induced Control of
    Schleicher U; Liese J; Justies N; Mischke T; Haeberlein S; Sebald H; Kalinke U; Weiss S; Bogdan C
    Front Immunol; 2018; 9():79. PubMed ID: 29459858
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Deletion of Interleukin-4 Receptor Alpha-Responsive Keratinocytes in BALB/c Mice Does Not Alter Susceptibility to Cutaneous Leishmaniasis.
    Govender M; Hurdayal R; Martinez-Salazar B; Gqada K; Pillay S; Gcanga L; Passelli K; Nieuwenhuizen NE; Tacchini-Cottier F; Guler R; Brombacher F
    Infect Immun; 2018 Dec; 86(12):. PubMed ID: 30275010
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Vaccination with the Leishmania infantum acidic ribosomal P0 protein plus CpG oligodeoxynucleotides induces protection against cutaneous leishmaniasis in C57BL/6 mice but does not prevent progressive disease in BALB/c mice.
    Iborra S; Carrión J; Anderson C; Alonso C; Sacks D; Soto M
    Infect Immun; 2005 Sep; 73(9):5842-52. PubMed ID: 16113303
    [TBL] [Abstract][Full Text] [Related]  

  • 34. The absence of cutaneous lymph nodes results in a Th2 response and increased susceptibility to Leishmania major infection in mice.
    Ehrchen JM; Roth J; Roebrock K; Varga G; Domschke W; Newberry R; Sorg C; Müller-Tidow C; Sunderkötter C; Kucharzik T; Spahn TW
    Infect Immun; 2008 Sep; 76(9):4241-50. PubMed ID: 18625738
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Differential regulation of IL-9-expression after infection with Leishmania major in susceptible and resistant mice.
    Gessner A; Blum H; Röllinghoff M
    Immunobiology; 1993 Dec; 189(5):419-35. PubMed ID: 8125519
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Leishmania major p27 gene knockout as a novel live attenuated vaccine candidate: Protective immunity and efficacy evaluation against cutaneous and visceral leishmaniasis in BALB/c mice.
    Elikaee S; Mohebali M; Rezaei S; Eslami H; Khamesipour A; Keshavarz H; Eshraghian MR
    Vaccine; 2019 May; 37(24):3221-3228. PubMed ID: 31047672
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Critical contribution of OX40 ligand to T helper cell type 2 differentiation in experimental leishmaniasis.
    Akiba H; Miyahira Y; Atsuta M; Takeda K; Nohara C; Futagawa T; Matsuda H; Aoki T; Yagita H; Okumura K
    J Exp Med; 2000 Jan; 191(2):375-80. PubMed ID: 10637281
    [TBL] [Abstract][Full Text] [Related]  

  • 38. TLR9-dependent activation of dendritic cells by DNA from Leishmania major favors Th1 cell development and the resolution of lesions.
    Abou Fakher FH; Rachinel N; Klimczak M; Louis J; Doyen N
    J Immunol; 2009 Feb; 182(3):1386-96. PubMed ID: 19155485
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Blocking junctional adhesion molecule C enhances dendritic cell migration and boosts the immune responses against Leishmania major.
    Ballet R; Emre Y; Jemelin S; Charmoy M; Tacchini-Cottier F; Imhof BA
    PLoS Pathog; 2014 Dec; 10(12):e1004550. PubMed ID: 25474593
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Vaccination with plasmacytoid dendritic cells induces protection against infection with Leishmania major in mice.
    Remer KA; Apetrei C; Schwarz T; Linden C; Moll H
    Eur J Immunol; 2007 Sep; 37(9):2463-73. PubMed ID: 17705130
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 17.